Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2008-07-03
2010-11-16
Weddington, Kevin (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
Reexamination Certificate
active
07834058
ABSTRACT:
A method of treating hyperinsulinemia. The method includes administering a therapeutically effective amount of a compound selected from the group consisting of catalpic acid, glyceride esters thereof, pharmaceutically-suitable salts thereof, and combinations thereof. The compound may be administered orally or parenterally.
REFERENCES:
patent: 6451439 (2002-09-01), Okamoto et al.
patent: 6593514 (2003-07-01), Cahoon et al.
patent: 2002/0045232 (2002-04-01), Qiu
patent: 2003/0126640 (2003-07-01), Cahoon et al.
patent: 2004/0121979 (2004-06-01), Susilo
patent: 1 175 901 (2002-01-01), None
patent: 2002-176913 (2002-06-01), None
www.mayoclinic.com/health/hyperinsulinemia (1998-2009).
U.S. Appl. No. 11/287/588, filed Jul. 20, 2006, Bassaganya-Riera.
Bassaganya-Riera, J., K. Reynolds, et al. (2004). “Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease.”Gastroenterology127(3): 777-91.
Center for Disease Control (2004).National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2003. Atlanta, U.S. Department of Health and Human Services, Centers for Disease control and Prevention.
Ginsberg, H. N. (2003). “Treatment for patients with the metabolic syndrome.”Am J Cardiol91(7A): 29E-39E.
Wang, Y. X., C. H. Lee, et al. (2003). “Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity.”Cell113(2): 159-70.
Blasiole Daniel A.
Dewitt Ross & Stevens S.C.
Nutrition Therapeutics, Inc.
Sara, Esq. Charles S.
Weddington Kevin
LandOfFree
Method of using catalpic acid to treat hyperinsulinemia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of using catalpic acid to treat hyperinsulinemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using catalpic acid to treat hyperinsulinemia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4187283